LLY
Eli Lilly and Company
LLY has the edge over MOVE overall, supported by stronger fundamentals and stronger valuation.
MOVE
Movano Inc.
MOVE's outlook is improving, though it still trails on the overall score.
LLY Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Strong | |
| Healthy |
LLY's revenue, profitability, cash flow and balance sheet are all currently healthy.
MOVE Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Under pressure | |
| Weak | |
| Unavailable |
MOVE's revenue is currently strong, but its profitability and cash flow are under pressure. There isn't enough data to rate its balance sheet.
LLY PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 27x | $845 | -41% |
| Forward | 30x | $1,427 | — |
| Current | 46x | $1,427 | — |
| Fair | 48x | $1,466 | +2.7% |
| Expensive | 85x | $2,612 | +83% |
Historical ranges are pointers, not guarantees.
LLY's PE is in its fair range at 46x. If earnings grow as analysts expect, today's price would be 30x next year's earnings, in its cheap range.
MOVE PE Valuation
MOVE has no meaningful PE right now: it lost money over the past year.
LLY Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect strong earnings and revenue growth for LLY, with profitability improving.
MOVE Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| -- | |
| Limited | |
| High |
Analysts expect MOVE's losses to shrink, with revenue growing.
LLY Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $46.82 | +52% |
| Q3 2026 | $30.81 | +51% |
| Q2 2026 | $29.80 | +95% |
| Q1 2026 | $28.15 | +129% |
| Q4 2025 | $22.95 | +96% |
| Q3 2025 | $20.44 | +121% |
| Q2 2025 | $15.30 | +88% |
| Q1 2025 | $12.29 | +81% |
| Q4 2024 | $11.71 | +102% |
LLY has the edge over MOVE on earnings quality, reporting a profit while its opponent remains loss making.
MOVE Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | -$18.64 | +$10.13 |
| Q1 2026 | -$17.62 | +$16.05 |
| Q4 2025 | -$21.79 | +$19.58 |
| Q3 2025 | -$22.90 | +$25.20 |
| Q2 2025 | -$28.77 | +$35.73 |
| Q1 2025 | -$33.67 | +$47.33 |
| Q4 2024 | -$41.37 | +$53.13 |
| Q3 2024 | -$48.10 | +$67.40 |
MOVE is still losing money, but far less than before: $18.64 per share over the past year, against $227.31 at its worst in late 2021.
LLY Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $24.4B | +39% |
| Q2 2026 | $23B | +48% |
| Q1 2026 | $19.8B | +56% |
| Q4 2025 | $19.3B | +43% |
| Q3 2025 | $17.6B | +54% |
| Q2 2025 | $15.6B | +38% |
| Q1 2025 | $12.7B | +45% |
| Q4 2024 | $13.5B | +45% |
LLY has the edge over MOVE on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 34% | -6.6 points |
| Q2 2026 | 40% | -3.3 points |
| Q1 2026 | 45% | +18 points |
| Q4 2025 | 43% | +5.6 points |
| Q3 2025 | 41% | +27 points |
| Q2 2025 | 44% | +12 points |
| Q1 2025 | 27% | -1.8 points |
| Q4 2024 | 37% | +10 points |
LLY has the edge over MOVE on profitability, with a higher operating margin.
MOVE Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $5M | +6128% |
| Q2 2026 | $3.8M | +3590% |
| Q1 2026 | $510K | +148% |
| Q4 2025 | $44K | -60% |
| Q3 2025 | $80K | +60% |
| Q2 2025 | $103K | +348% |
| Q1 2025 | $206K | -76% |
MOVE's revenue is growing: $5M last quarter, up 6128% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -350% | +2889 points |
| Q2 2026 | -400% | +2765 points |
| Q1 2026 | -950% | +1592 points |
| Q4 2025 | -10032% | -5805 points |
| Q3 2025 | -3239% | +11519 points |
| Q2 2025 | -3165% | +24648 points |
| Q1 2025 | -2543% | -1867 points |
| Q4 2024 | -4227% | N/A |
MOVE's operating margin was −350% last quarter, up 2889 points from the same quarter a year ago, near the top of its range since 2024.
LLY Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $8.2B | +22% |
| Q2 2026 | $7.8B | +458% |
| Q1 2026 | $3B | +1826% |
| Q4 2025 | $677.9M | -31% |
| Q3 2025 | $6.7B | +186% |
| Q2 2025 | $1.4B | +476% |
| Q1 2025 | $156.1M | -13% |
| Q4 2024 | $977.8M | +$2.4B |
LLY has the stronger cash trend. Its trailing FCF is up 259% versus its history, compared with MOVE at down 70%.
MOVE Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q4 2025 | -$2.3M | +$2.3M |
| Q4 2024 | -$4.6M | +$702K |
| Q3 2024 | -$5.7M | +$1.3M |
| Q2 2024 | -$8.2M | -$262K |
| Q1 2024 | -$4.1M | +$2M |
| Q4 2023 | -$5.3M | +$1.1M |
| Q3 2023 | -$7M | -$517K |
| Q2 2023 | -$7.9M | -$1.5M |
MOVE has burned cash in almost every quarter: −$35M over the past year, against −$23M the year before.
LLY Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | -300K shares |
| 1 year | -0.6% | -5.4M shares |
| 3 years | -0.7% | -6.4M shares |
| 5 years | -1.9% | -17.4M shares |
| Available history | -4.5% | -42.3M shares |
LLY has the edge over MOVE on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $377M |
| Q2 2026 | $1.6B |
| Q1 2026 | $2.4B |
| Q4 2025 | $1.5B |
| Q3 2025 | $708.1M |
| Q2 2025 | $692.2M |
| Q1 2025 | $1.2B |
| Q4 2024 | $2.1B |
LLY spent $5.8B buying back its own shares over the past year, up 26% from the year before.
MOVE Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +54% | +878K shares |
| 1 year | +252% | +1.8M shares |
| 3 years | +1041% | +2.3M shares |
| 5 years | +17% | +365K shares |
MOVE has 3M diluted shares, up 252% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2020 | — |
| Q3 2020 | — |
| Q2 2020 | — |
| Q1 2020 | — |
| Q4 2019 | — |
LLY Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.2x | Healthy |
| Q2 2026 | 1.3x | Healthy |
| Q1 2026 | 1.2x | Healthy |
| Q4 2025 | 1.3x | Healthy |
| Q3 2025 | 1.3x | Healthy |
| Q2 2025 | 2.0x | Healthy |
| Q1 2025 | 2.3x | Moderate |
| Q4 2024 | 2.1x | Moderate |
LLY's net debt is about 1.2 years of its operating earnings (EBITDA), about the same as a year ago.
MOVE Net Leverage
MOVE's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
LLY Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 68.3 | Neutral |
| Stochastic | 84.1 | Overbought |
LLY's weekly RSI is 68 (neutral) and its Stochastic is 84 (overbought).
MOVE Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 36.2 | Neutral |
| Stochastic | 1.9 | Oversold |
MOVE's weekly RSI is 36 (neutral) and its Stochastic is 2 (oversold).
LLY PE vs Healthcare Sector
| Metric | LLY | Sector median | Relative |
|---|---|---|---|
| PE | 46x | 26x | 79% above |
| PE % | 48 | 29 | 19 pts above |
LLY is trading at 46x earnings, a 79% premium to the Healthcare sector's median of 26x.
MOVE PE vs Healthcare Sector
MOVE has no meaningful PE right now: it lost money over the past year.
LLY Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1,279.4 | 12% above |
| 20 week MA | $1,218.8 | 17% above |
| 50 week MA | $1,102.2 | 29% above |
| 100 week MA | $954.1 | 50% above |
| 200 week MA | $797.5 | 79% above |
LLY has the edge over MOVE on trend strength, trading above more of its moving averages.
MOVE Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $8.27 | 43% below |
| 20 week MA | $11.0 | 57% below |
| 50 week MA | $12.7 | 63% below |
| 100 week MA | $16.0 | 70% below |
| 200 week MA | $66.2 | 93% below |
MOVE is in a downtrend: it's below all five of its weekly moving averages, and 93% below its 200-week average.
LLY Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $131.5 | $166.7 | +27% |
| 2021 | $166.7 | $273.1 | +64% |
| 2022 | $273.1 | $367.9 | +35% |
| 2023 | $367.9 | $582.9 | +58% |
| 2024 | $582.9 | $783.2 | +34% |
| 2025 | $783.2 | $1,077.8 | +38% |
| 2026 YTD | $1,077.8 | $1,427.3 | +32% |
LLY has the edge over MOVE on returns for 2026, with the stronger performance.
MOVE Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $846.0 | $447.0 | -47% |
| 2022 | $447.0 | $219.0 | -51% |
| 2023 | $219.0 | $117.2 | -46% |
| 2024 | $117.2 | $58.5 | -50% |
| 2025 | $58.5 | $8.14 | -86% |
| 2026 YTD | $8.14 | $4.71 | -42% |
MOVE has finished every year since 2021 lower, and it's down 42% so far in 2026.